Our very own Dr. Sylvia recently joined the Global Advisory Board for Botox® in Miami on the 9th and 10th of November. The event was organized by Allergan, Inc., the company behind the popular neurotoxin brand. The discussions focused on critical topics in the field of Botox®.
Dr. Sylvia’s participation in this crucial event demonstrated her commitment to staying up to date with all the advances in the medical aesthetic field. This recent opportunity, where she was part of a global network of experts, enables her to deliver safe, effective, and quality medical aesthetic services to her patients.
Microneedling, which involves creating microscopic punctures in the skin to stimulate collagen, has been popular…
Cutis is thrilled to introduce VYC-12, a US FDA-approved hyaluronic acid microdroplet injectable. Indicated to…
Worried about blemishes and uneven skin tone? While a good skin care regimen can help…
The US Food and Drug Administration (FDA) has approved Allergan’s OnabotulinumtoxinA for treating moderate to…
The term “cortisol face” has created a buzz on social media (especially TikTok), with many…
On average, the skin renewal process takes about 28 days. This helps make sure that…